Genetic factors may also play a role in an individual's predisposition to IFD; mutation of the FLT3 gene – common in patients with AML [28] – may potentially result in an intrinsic predisposition to IFD or a reduced susceptibility to antifungal prophylaxis. The gene discussed is FLT3; the disease is acute myeloid leukemia.